SitesBLAST
Comparing WP_011386051.1 NCBI__GCF_000009985.1:WP_011386051.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
5da0A Structure of the the slc26 transporter slc26dg in complex with a nanobody (see paper)
27% identity, 89% coverage: 34:540/569 of query aligns to 9:467/467 of 5da0A
Sites not aligning to the query:
Q55415 Bicarbonate transporter BicA from Synechocystis sp. (strain PCC 6803 / Kazusa) (see paper)
29% identity, 94% coverage: 34:569/569 of query aligns to 13:548/564 of Q55415
- T69 (= T90) binding hydrogencarbonate; mutation to A: Alters bicarbonate transport.
- D258 (≠ E275) binding Na(+); mutation D->A,E: Alters bicarbonate transport.
- T262 (≠ S279) binding Na(+); mutation to A: Alters bicarbonate transport.
- G300 (= G317) binding Na(+)
- A301 (= A318) binding hydrogencarbonate
- T302 (≠ I319) binding Na(+); mutation to A: Alters bicarbonate transport.
- A471 (≠ R490) mutation to N: Alters bicarbonate transport.
- L476 (≠ M496) mutation to S: Alters bicarbonate transport.
- A486 (≠ G506) mutation to E: Alters bicarbonate transport.
- L490 (= L510) mutation to Q: Alters bicarbonate transport.
6ki1B The transmembrane domain of a cyanobacterium bicarbonate transporter bica (see paper)
32% identity, 66% coverage: 34:409/569 of query aligns to 12:391/392 of 6ki1B
7v75A Thermostabilized human prestin in complex with salicylate (see paper)
27% identity, 90% coverage: 35:545/569 of query aligns to 25:578/605 of 7v75A
7v74A Thermostabilized human prestin in complex with sulfate (see paper)
27% identity, 92% coverage: 35:559/569 of query aligns to 25:586/597 of 7v74A
7lhvA Structure of arabidopsis thaliana sulfate transporter atsultr4;1 (see paper)
25% identity, 92% coverage: 36:559/569 of query aligns to 29:570/575 of 7lhvA
- binding 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine: L126 (≠ A126), R127 (= R127), W130 (≠ V130)
- binding (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate: L128 (≠ F128), L131 (≠ V131), E409 (≠ D404), L413 (≠ A408), G417 (= G412), A421 (= A416)
- binding sulfate ion: A84 (≠ G91), S321 (≠ A318), F322 (≠ I319)
Q8CIW6 Solute carrier family 26 member 6; Anion exchange transporter; Chloride-formate exchanger; Pendrin-L1; Pendrin-like protein 1; Putative anion transporter-1; Pat-1 from Mus musculus (Mouse) (see paper)
27% identity, 78% coverage: 43:484/569 of query aligns to 102:564/758 of Q8CIW6
- F552 (= F472) mutation to A: Does not inhibit formate transport in PMA-induced cells.
A0FKN5 Prestin; Solute carrier family 26 member 5 from Gallus gallus (Chicken) (see paper)
26% identity, 68% coverage: 35:423/569 of query aligns to 83:508/742 of A0FKN5
- S404 (≠ A320) Controls the anion transport; mutation to A: Alters anion selectivity.; mutation to C: Abolishes sulfate transport. Does not affect oxalate transport. Is accesible both from extracellular and intracellular side by methane-thiosulphonate (MTS) reagents. Inhibits divalent transport upon extracellular application of (2-sulphonatoethyl)methane-thiosulphonate (MTSES) but not [2-(trimethylammonium)ethyl]methane-thiosulphonate (MTSET). Abolishes anion transport upon intracellular MTSET application.
- R405 (= R321) mutation to C: Fully abolishes anion transport.
Q9BXS9 Solute carrier family 26 member 6; Anion exchange transporter; Pendrin-like protein 1; Pendrin-L1 from Homo sapiens (Human) (see 3 papers)
25% identity, 78% coverage: 43:484/569 of query aligns to 100:563/759 of Q9BXS9
- N167 (≠ Y106) modified: carbohydrate, N-linked (GlcNAc) asparagine; mutation to Q: Reduced chloride oxalate exchanger activity.
- N172 (≠ L111) modified: carbohydrate, N-linked (GlcNAc) asparagine; mutation to Q: Reduced chloride oxalate exchanger activity.
- V206 (= V131) to M: in dbSNP:rs13324142
- ATV 547:549 (≠ GPF 468:470) mutation to NVN: Does not inhibit cell membrane localization. Inhibits interaction with CA2 and bicarbonate transport.
- N553 (≠ V474) mutation to A: Does not inhibit interaction with CA2. Inhibits interaction with CA2 and bicarbonate transport in PMA-induced cells.
Sites not aligning to the query:
- 582 S→A: Does not inhibit interaction with CA2. Does not inhibit interaction with CA2 and bicarbonate transport in PMA-induced cells.
8sieC Pendrin in complex with bicarbonate (see paper)
22% identity, 99% coverage: 3:564/569 of query aligns to 7:612/613 of 8sieC
- binding Lauryl Maltose Neopentyl Glycol: G198 (≠ A169), S296 (≠ T259), T300 (≠ Q263), F303 (= F266)
- binding bicarbonate ion: Y65 (≠ L54), F101 (≠ T90), L356 (≠ I319), S357 (≠ A320), V403 (≠ L366), N406 (≠ V369)
- binding cholesterol: L226 (= L197), V255 (≠ A220), I262 (≠ L227), Y272 (≠ R237), F411 (= F379), V414 (≠ L382), V414 (≠ L382), C415 (≠ M383), C415 (≠ M383), I436 (≠ L415), M452 (≠ G431), F453 (≠ T432)
- binding 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine: W421 (≠ D389), V429 (≠ A408), V432 (= V411), F433 (≠ G412), I436 (≠ L415)
8shcC Pendrin in complex with niflumic acid (see paper)
22% identity, 99% coverage: 3:564/569 of query aligns to 7:612/613 of 8shcC
- binding cholesterol: I199 (vs. gap), A223 (= A194), V255 (≠ A220), Y272 (≠ R237), M412 (≠ I380), C415 (≠ M383), M452 (≠ G431), F453 (≠ T432)
- binding 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine: Q156 (≠ R127), W421 (≠ D389), V432 (= V411), F433 (≠ G412), F455 (≠ I434)
- binding 2-{[3-(trifluoromethyl)phenyl]amino}nicotinic acid: Y65 (≠ L54), F101 (≠ T90), T173 (= T144), E252 (≠ V217), I312 (≠ E275), L356 (≠ I319), S357 (≠ A320), V402 (= V365), N406 (≠ V369)
8sh3C Pendrin in complex with iodide (see paper)
22% identity, 99% coverage: 3:564/569 of query aligns to 7:612/613 of 8sh3C
- binding Lauryl Maltose Neopentyl Glycol: S114 (vs. gap), G198 (≠ A169), E297 (≠ A260), T300 (≠ Q263), F303 (= F266)
- binding cholesterol: I199 (vs. gap), A223 (= A194), V255 (≠ A220), I258 (≠ L223), I262 (≠ L227), Y272 (≠ R237), F411 (= F379), V414 (≠ L382), C415 (≠ M383), V417 (≠ A385), I439 (= I418), M452 (≠ G431), F453 (≠ T432)
- binding iodide ion: Y65 (≠ L54), N406 (≠ V369)
- binding 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine: L155 (≠ A126), F159 (≠ V130), W421 (≠ D389), V429 (≠ A408), V432 (= V411), F433 (≠ G412), I436 (≠ L415), L451 (≠ I430), F455 (≠ I434), F464 (≠ D443), P465 (≠ G444)
8sgwC Pendrin in complex with chloride (see paper)
22% identity, 99% coverage: 3:564/569 of query aligns to 7:612/613 of 8sgwC
- binding Lauryl Maltose Neopentyl Glycol: G198 (≠ A169), S296 (≠ T259), T300 (≠ Q263), F303 (= F266)
- binding chloride ion: Y65 (≠ L54), N406 (≠ V369)
- binding cholesterol: I228 (≠ V199), V255 (≠ A220), I262 (≠ L227), Y272 (≠ R237), K408 (≠ W371), F411 (= F379), M412 (≠ I380), M412 (≠ I380), V414 (≠ L382), C415 (≠ M383), V417 (≠ A385), I439 (= I418)
- binding 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine: F159 (≠ V130), Y163 (= Y134), F284 (vs. gap), P286 (vs. gap), I289 (≠ F250), F343 (≠ A306), F346 (≠ L309), W421 (≠ D389), F433 (≠ G412), I436 (≠ L415), F455 (≠ I434), F464 (≠ D443), P465 (≠ G444)
7xujA Human slc26a3 in complex with uk5099
25% identity, 77% coverage: 35:473/569 of query aligns to 68:525/703 of 7xujA
- binding (E)-2-cyano-3-(1-phenylindol-3-yl)prop-2-enoic acid: V79 (= V46), Q83 (≠ L50), E271 (≠ G212), S376 (≠ A320), R377 (= R321), V380 (≠ T324), L421 (vs. gap), A422 (≠ P358), N425 (≠ S361)
- binding cholesterol hemisuccinate: F171 (= F123), V311 (≠ P248), Q315 (≠ A252)
7xuhA Down-regulated in adenoma in complex with tqr1122
24% identity, 77% coverage: 35:473/569 of query aligns to 68:529/707 of 7xuhA
- binding 2-[4,8-dimethyl-2-oxidanylidene-7-[[3-(trifluoromethyl)phenyl]methoxy]chromen-3-yl]ethanoic acid: P124 (vs. gap), I125 (vs. gap), L187 (≠ I135), I192 (≠ V140), F195 (= F143), V335 (≠ I268), S338 (vs. gap), S380 (≠ A320), M433 (≠ V365)
- binding cholesterol hemisuccinate: V223 (≠ A169), F226 (= F172), K227 (≠ E173), Y230 (≠ V176), F318 (≠ P251), Q319 (≠ A252)
7xulA Human slc26a3 in complex with tenidap
24% identity, 87% coverage: 35:528/569 of query aligns to 61:558/690 of 7xulA
- binding 5-chloranyl-2-oxidanyl-3-thiophen-2-ylcarbonyl-indole-1-carboxamide: V72 (= V46), L75 (≠ P49), Q76 (≠ L50), E262 (≠ G212), S367 (≠ A320), L412 (vs. gap), N416 (≠ S361)
- binding cholesterol hemisuccinate: I157 (≠ V118), F162 (= F123), P209 (= P168), K214 (≠ E173), Y217 (≠ V176), V302 (≠ P248), Q306 (≠ A252), V309 (≠ W255), V450 (≠ M402)
Q9URY8 Probable sulfate permease C869.05c from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
24% identity, 59% coverage: 35:367/569 of query aligns to 123:480/840 of Q9URY8
Sites not aligning to the query:
- 823 modified: Phosphoserine
Q9EPH0 Prestin; Solute carrier family 26 member 5 from Rattus norvegicus (Rat) (see 3 papers)
22% identity, 79% coverage: 35:484/569 of query aligns to 82:558/744 of Q9EPH0
- L104 (≠ A57) mutation to C: Is accessible from the extracellular side after extracellular application of thiol-reactive reagents.
- V149 (≠ Q102) mutation to C: Is accessible from the extracellular side after extracellular application of thiol-reactive reagents.
- D154 (= D107) mutation to N: Shifts the voltage-sensitivity to more negative values.
- D155 (≠ G108) mutation to N: Shifts the voltage-sensitivity to more negative values.
- E169 (vs. gap) mutation to Q: No effect.
- K177 (vs. gap) mutation to Q: No effect.
- R197 (= R127) mutation to Q: Shifts the voltage-sensitivity to more negative values.
- A202 (≠ I132) mutation to C: Is only accessible to the intracellular side application of thiol-reactive reagents. Is not affected by thiol-reactive reagents extracellular side application.
- K233 (≠ R163) mutation to Q: Shifts the voltage-sensitivity to more negative values; when associated with Q-235 and Q-236.
- K235 (≠ E165) mutation to Q: Shifts the voltage-sensitivity to more negative values; when associated with Q-233 and Q-236.
- R236 (≠ S166) mutation to C: Is accessible from the extracellular side after extracellular application of thiol-reactive reagents.; mutation to Q: Shifts the voltage-sensitivity to more negative values; when associated with Q-233 and Q-235.
- K276 (vs. gap) mutation to C: Is only accessible to the intracellular side application of thiol-reactive reagents. Is not affected by thiol-reactive reagents extracellular side application.
- E277 (vs. gap) mutation to Q: Shifts the voltage-sensitivity to slightly more positive values.
- R281 (= R205) mutation to Q: No effect; when associated with Q-283 and Q-285.
- K283 (≠ R207) mutation to Q: No effect; when associated with Q-218 and Q-285.
- K285 (≠ G209) mutation to Q: No effect; when associated with Q-281 and Q-283.
- P331 (= P246) mutation to C: Is accessible from the extracellular side after extracellular application of thiol-reactive reagents.
- D332 (≠ S247) mutation to Q: No effect.
- D342 (≠ K257) mutation to Q: Shifts the voltage-sensitivity to more positive values.
- K359 (≠ M281) mutation to C: Is only accessible to the intracellular side application of thiol-reactive reagents. Is not affected by thiol-reactive reagents extracellular side application.
- Q389 (≠ G311) mutation to C: Is accessible from the extracellular side after extracellular application of thiol-reactive reagents.
- S398 (≠ A320) Controls the electromotile activity; mutation to C: Does not affect anion-dependent electromotility-related charge movement. Strongly attenuates inhibition by oxalate of electromotility-related charge movement. Is sensible to intracellular thiol-reactive reagents. Is completely insensitive to both reagents applied to the extracellular face of the membrane. Strongly affects the interaction with oxalate.
- R399 (= R321) Contributes to anion binding; mutation to C: Largely abolishes anion-dependent electromotility-related charge movement.; mutation to E: Fully abolishes anion-dependent electromotility-related charge movement.; mutation to K: Does not affect anion-dependent electromotility-related charge movement.; mutation to Q: Fully abolishes anion-dependent electromotility-related charge movement.; mutation to S: Does not affect anion-dependent electromotility-related charge movement. Abrogates salicylate inhibition of electromotility-related charge movement.
- G408 (≠ A330) mutation to C: Is only accessible to the intracellular side application of thiol-reactive reagents. Is not affected by thiol-reactive reagents extracellular side application.
- K409 (≠ Q331) mutation to Q: No effect.
- L431 (= L353) mutation to C: Is accessible from the extracellular side after extracellular application of thiol-reactive reagents.
- S465 (≠ P386) mutation to C: Is only accessible to the intracellular side application of thiol-reactive reagents. Is not affected by thiol-reactive reagents extracellular side application.
- D485 (≠ T406) mutation to C: Is accessible from the extracellular side after extracellular application of thiol-reactive reagents.
- K557 (≠ E483) mutation to Q: No effect; when associated with Q-558 and Q-559.
- R558 (≠ Q484) mutation to Q: No effect; when associated with Q-557 and Q-559.
Sites not aligning to the query:
- 505:718 Extended region for STAS domain
- 559 K→Q: No effect; when associated with Q-557 and Q-558.
- 571 R→Q: Shifts the voltage-sensitivity to slightly more positive values; when associated with Q-572 and Q-577.
- 572 R→Q: Shifts the voltage-sensitivity to slightly more positive values; when associated with Q-571 and Q-577.
- 577 K→Q: Shifts the voltage-sensitivity to slightly more positive values; when associated with Q-571 and Q-572.
D7PC76 Prestin; Solute carrier family 26 member 5 from Tursiops truncatus (Atlantic bottle-nosed dolphin) (Delphinus truncatus) (see paper)
22% identity, 81% coverage: 35:497/569 of query aligns to 82:571/741 of D7PC76
- GG 274:275 (vs. gap) mutation to LV: Abolishes non-linear capacitance. Does not affect protein expression.
- S398 (≠ A320) binding salicylate
7lguA Structure of human prestin in the presence of nacl (see paper)
23% identity, 79% coverage: 35:484/569 of query aligns to 70:546/680 of 7lguA
Query Sequence
>WP_011386051.1 NCBI__GCF_000009985.1:WP_011386051.1
MSERPTFMPARLINLFTPKLLVCLKEGYDLPRGRGDLIAGLTVAIVALPLAMALGIASGV
TPDRGLFTAIVAGFLISFLGGSRFQIGGPTGAFVVVVYNIVQQHGYDGLVLATLMAGVML
LLFGLARFGVVIKYIPYPLVTGFTSGIAVIIFSSQVKDFLGLRMESVPAEFFEKWVAYGE
HIGTTHGPTLAVAAGTLAVILVLRRFRPGWPGFLIGVTGASVLVWALGMPVETIGSRFGG
IPSTLPSPQFPALSWGKVTALLQPAFTIAFLAGIESLLSAMVADGMTGRRHKSNCELLAQ
GIANIASVLFGGIPATGAIARTATSIKSGAQTPVAGMLHAVFILLFMLLFAPLASWIPLP
SLAAVLMVVAWNMSEAPHFIHLMSAPRSDRAVLLVTFVLTVMVDLTVAIEVGMVLASILF
MRRMAEVTEIGTGIHLIDEDAEDGGDDHVGAIPTTPIPDGVEVFQISGPFFFGVATRLSE
VFEQTHKPPRVFILRMRLVPVIDASGIQALTEFVRRCRKHGTEVLLSGVQPQPMQVMGRM
GLCHEIGEDNFVPNIDAALTTARTLAVHP
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory